BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27547135)

  • 1. Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.
    Park K; Lai D; Handberg EM; Moyé L; Perin EC; Pepine CJ; Anderson RD
    Tex Heart Inst J; 2016 Aug; 43(4):291-6. PubMed ID: 27547135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unipolar voltage abnormality is associated with greater left ventricular dysfunction in ischemic cardiomyopathy.
    Aldhoon B; Frankel DS; Hutchinson MD; Callans DJ; Epstein AE; Dixit S; Riley MP; Lin D; Garcia FC; Supple GE; Cooper JM; Bala R; Deo R; Zado ES; Marchlinski FE
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):293-8. PubMed ID: 24237590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of improvement in left ventricular ejection fraction versus improvement in heart failure symptoms after coronary revascularization in patients with ischemic cardiomyopathy.
    Rizzello V; Poldermans D; Biagini E; Schinkel AF; Elhendy A; Leone AM; Crea F; Maat A; Roelandt JR; Bax JJ
    Am J Cardiol; 2005 Aug; 96(3):386-9. PubMed ID: 16054464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia.
    Haqqani HM; Kalman JM; Roberts-Thomson KC; Balasubramaniam RN; Rosso R; Snowdon RL; Sparks PB; Vohra JK; Morton JB
    J Am Coll Cardiol; 2009 Jul; 54(2):166-73. PubMed ID: 19573735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy.
    Eisen HJ
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):520-1. PubMed ID: 18648335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
    Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Carvalho AC; Dutra HS; Dohmann HJ; Silva GV; Belém L; Vivacqua R; Rangel FO; Esporcatte R; Geng YJ; Vaughn WK; Assad JA; Mesquita ET; Willerson JT
    Circulation; 2003 May; 107(18):2294-302. PubMed ID: 12707230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials.
    Tian T; Chen B; Xiao Y; Yang K; Zhou X
    Atherosclerosis; 2014 Apr; 233(2):485-492. PubMed ID: 24530783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
    Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
    Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy.
    Samady H; Liu YH; Choi CJ; Ragosta M; Pfau SE; Cleman MW; Powers ER; Kramer CM; Wackers FJ; Beller GA; Watson DD
    Am J Cardiol; 2003 Apr; 91(7):807-11. PubMed ID: 12667565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study.
    Pokushalov E; Romanov A; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Poveshenko O; Kliver E; Shirokova N; Karaskov A; Dib N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):160-8. PubMed ID: 20560030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia.
    Hsia HH; Callans DJ; Marchlinski FE
    Circulation; 2003 Aug; 108(6):704-10. PubMed ID: 12885746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.
    Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y
    Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
    Rodrigo SF; van Ramshorst J; Beeres SL; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Schalij MJ; Bax JJ; Atsma DE
    Am Heart J; 2012 Nov; 164(5):771-8. PubMed ID: 23137509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of a prospective, randomised study of retrograde application of bone marrow aspirate concentrate (BMAC) through coronary sinus in patients with congestive heart failure of ischemic etiology (the RETRO study).
    Pleva L; Kukla P; Vítková K; Procházka V
    BMC Cardiovasc Disord; 2019 Jan; 19(1):32. PubMed ID: 30704414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation.
    Koplan BA; Soejima K; Baughman K; Epstein LM; Stevenson WG
    Heart Rhythm; 2006 Aug; 3(8):924-9. PubMed ID: 16876741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical intramyocardial stem cell therapy for chronic ischemic heart failure].
    Kaminski A; Donndorf P; Klopsch C; Steinhoff G
    Herz; 2010 Aug; 35(5):324-33. PubMed ID: 20625690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF).
    Santoso T; Siu CW; Irawan C; Chan WS; Alwi I; Yiu KH; Aziz A; Kwong YL; Tse HF
    J Cardiovasc Transl Res; 2014 Aug; 7(6):545-52. PubMed ID: 25079593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.
    Nso N; Bookani KR; Enoru ST; Radparvar F; Gordon R
    Heart Fail Rev; 2022 May; 27(3):811-820. PubMed ID: 33587248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.